According to the Zhitong Finance App, Yingtai Healthcare (01501) announced interim results for the six months ended June 30, 2026. The group obtained revenue of 596 million yuan, an increase of 29.28% over the previous year; profit attributable to the company's equity shareholders was 110 million yuan, an increase of 11.97% over the previous year; and profit per share was 0.54 yuan.

According to the announcement, the increase in revenue was mainly due to acquisitions and mergers and acquisitions filling the product gap, constructing a complete product category matrix; and achieving synergy effects through channel reuse and supply chain integration, thereby boosting the sales volume of interventional medical devices.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.